Li Kang Biomedical Co., Ltd. (TPEX:6242)

Market Cap	1.21B -18.9%
Revenue (ttm)	589.21M +4.2%
Net Income	83.82M +8.8%
EPS	2.62 +6.1%
Shares Out	31.81M
PE Ratio	14.50
Forward PE	n/a
Dividend	2.00 (5.26%)
Ex-Dividend Date	Jun 16, 2025

Volume	1,044
Average Volume	6,459
Open	37.60
Previous Close	38.00
Day's Range	37.60 - 38.10
52-Week Range	36.60 - 44.50
Beta	-0.05
RSI	52.82
Earnings Date	May 6, 2026

About Li Kang Biomedical

Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.

• Industry: Travel Services
• Sector: Consumer Discretionary
• Founded: 1982
• Employees: 122
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6242

Financial Performance

In 2025, Li Kang Biomedical's revenue was 589.21 million, an increase of 4.19% compared to the previous year's 565.52 million. Earnings were 83.82 million, an increase of 8.83%.